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Abstract
Patients who have received haematopoietic stem cell transplantation (HSCT) have a high rate of pulmonary com-
plications, and in this immunosuppressed population, fungal pneumonia is of great concern. Fungal pneumonia 
can have a similar appearance to non-infectious pulmonary processes in HSCT patients, and radiologists should be 
familiar with the subtle features that may help to differentiate these disease entities. The focus of this article is on the 
diagnosis of fungal pneumonia in HSCT patients with an emphasis on radiologists’ roles in establishing the diagnosis 
of fungal pneumonia and the guidance of clinical management.
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Introduction
Approximately 21,000 adults in the United States under-
went haematopoietic stem cell transplantation (HSCT) in 
2018, with numbers increasing each year [1]. Up to 60% 
of HSCT recipients develop life-threatening complications 
involving the pulmonary system, which are frequently 
attributable to either infectious (fungal, bacterial, viral) or 
non-infectious (idiopathic pneumonia syndrome, respira-
tory distress syndrome, diffuse alveolar haemorrhage, etc.) 
aetiologies [2,3]. This article focuses on various types of 
fungal pneumonia as an infectious complication of HSCT 
to emphasize the role of the radiologist in diagnosing and 
differentiating fungal pneumonia from its other mimics 
of bacterial and viral aetiologies, thereby guiding clinical 
management.
HSCT, also known as bone marrow transplantation, 
is used to treat multiple cancers including different types 
of leukaemias, lymphomas, multiple myeloma, as well as 
some solid tumours [4,5]. Types of HSCT include autolo-
gous HSCT (the patient’s own stem cells), allogenic (do-
nated by a related or non-related matched or non-matched 
individual), or syngeneic (donated by the patient’s identi-
cal twin). The 100-day mortality rate for HSCT can be as 
high as 40% in allotransplant HSCT patients, and 20% in 
autologous HSCT patients [2]. Pulmonary complications 
related to HSCT have been reported to occur in up to 60% 
of patients [2,3]. Complications related to HSCT can arise 
during both the pre-engraftment phase (0-30 days after 
transplant where neutropaenia is profound), early post-
engraftment (30-100 days, neutropaenia slowly recover-
ing), or late post-engraftment (> 100 days, neutropaenia 
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continues to recover), and these complications range from 
infectious to non-infectious aetiologies [2]. 
Fungal pneumonia is not frequently seen amongst the 
general population, with exceptions of certain endemic 
regions of the world (for example the Mississippi River 
Valley, Ohio River Valley, Southwestern United States, 
etc.) [6]. However, in the immunosuppressed population, 
fungal pneumonia becomes a greater concern and can re-
flect opportunistic (Candida, Aspergillus, or Mucormycosis 
species) or endemic origin (Blastomyces dermatitidis, Coc-
cidiodes immitis, and Histoplasma caspulatum) of infec-
tion (Table 1).
Risk factors for fungal pneumonia in HSCT vary de-
pending on the organism causing pneumonia and are 
summarized in more detail in Table 2. In general, factors 
contributing to fungal pneumonia include the patient’s 
primary malignancy, exposure, type of transplant, degree 
of immunosuppression, use of myeloablative regimen, 
concomitant infection, and occurrence of graft-versus-
host disease (GVHD) [7,8]. The complex cellular and 
biochemical pathways that provide resistance to fun-
gal pathogens in immunocompetent individuals can be 
disrupted for many reasons in HSCT patients. The first 
line of defence would ordinarily come from the sino-
pulmonary epithelial cells, which can be damaged by 
chemotherapy, radiation, and instrumentation (medi-
cal support devices), and post-transplant complications 
such as mucositis or GVHD [8,9]. Additionally, HSCT 
may have a suppressed immune system related to over-
all decreased leukocytes (neutropenia, T-cell depletion, 
etc.) and/or reduced immune response (for example, 
impaired neutrophil chemotaxis or myeloperoxidase 
activity) [8]. The latter may explain why some patients 
who are not neutropaenic still present with fungal pneu-
monia. 
Clinical manifestations
Patients who have undergone HSCT and are experienc-
ing pulmonary complications may not necessarily pres-
Table 2. Risk factors for fungal pneumonia in haematopoietic stem cell transplantation patients
Risk factor
Host factors Underlying hematologic malignancy. It is more common with AML and MDS followed by ALL and aplastic anaemia
Exposure Travel, gardening, construction work
Laboratory parameters Neutropaenia+++
Lymphopaenia++
Type of transplant Allogeneic HSCT patients have a higher prevalence of invasive fungal infections than autologous HSCT patients (5.8-8.1%  
vs. 1.2%, respectively) [11]
Conditioning regimen Myeloablative regimen
GVHD Acute GVHD has greater risk of invasive fungal pneumonia than chronic GVHD
Immunosuppression Myelosuppressive chemotherapy+++
Steroids > 1 mg/kg/d+++
Anti-T-cell therapy++
Other infections Cytomegalovirus (CMV) has been linked
AML – acute myelogenous leukaemia, MDS – myelodysplastic syndrome, ALL – acute lymphoblastic leukaemia, SCT – stem cell transplant, HCT – haematopoietic cell transplantation, 
GVHD – graft-versus-host disease.
+ indicates slightly increased risk of fungal pneumonia in HSCT patients. ++ indicates moderately increased risk of fungal pneumonia in haematopoietic stem cell transplantation (HSCT) patients. 
+++ indicates significantly increased risk of fungal pneumonia in HSCT patients.
Table 1. Examples of fungal pneumonia infectious organisms
Examples of fungal pneumonia infectious organisms
Aspergillus sp. A. flavus, A. fumigatus, A. lentulus, A. nidulans, A. niger, A. terreus
Cryptococcus sp. C. gatti, C. neoformans
Endemic mycoses Blastomyces dermatitdis, Coccidiodes immitis, Histoplasma caspulatum, Paracoccidioides brasiliensis
Fusarium sp. F. solani complex, F. oxysporum complex
Mucorales sp. (mucormycosis  
or zygomycosis)
Mucor spp., Rhizomucor spp., Rhizopus spp., Apophysomyces spp., Cunnighamella bertholletiae, Lichthemiaia 
corymbifera
Paecilomyces spp. P. varioti, P. lilacinum
Secdosporium spp. S. apiospermum, S. prolificans
Scopularopsis spp. S. brevicaulis
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ent with signs of infection (i.e. fever and leukocytosis) 
due to immunosuppression. Medical history including 
an underlying condition requiring HSCT, type of HSCT, 
elapsed time since HSCT, exposures, and adherence to 
post-transplant prophylaxis medications can aid in nar-
rowing the broad differential (Figure 1). Persistent fevers, 
cough, chest pain, and haemoptysis are a few of the clini-
cal features that can be encountered in cases of fungal 
pneumonia, which may trigger further investigation with 
radiological studies: chest radiographs and/or computed 
tomography (CT) [6]. 
Radiological features of fungal infections
Opportunistic fungi
Aspergillus 
Invasive pulmonary aspergillosis (IPA) caused by Aspergil-
lus is the most commonly reported invasive fungal infection 
seen in upwards of 40% of HSCT patients [10,11]. Risk fac-
tors for invasive Aspergillus pneumonia include allogeneic 
transplantation, prolonged neutropaenia, CMV infection, 
Figure 1. Timeline of infections more commonly encountered after haematopoietic stem cell transplantation and the prophylactic medications generally 
given to prevent them. Adapted from: Vazquez Guillamet et al. [24]
Figure 2. Aspergillus pneumonia. A) 56-year-old patient with acute myelogenous leukaemia undergoing pre-transplant conditioning presented with neu-
tropenic fever diagnosed with Aspergillus nigri pneumonia. Axial chest computed tomography (CT) shows multiple bilateral solid nodules (arrows) with 
adjacent ground-glass opacities (arrowhead). Small left pleural effusion is also present (star). B-E) Different patient with invasive Aspergillosis pneumonia. 
A 60-year-old woman with history of acute myelogenous leukaemia status post allogenic stem cell transplant, who presents with persistent fever and 
pancytopaenia. B) Frontal chest radiograph shows focal peripheral consolidation in the left upper lobe (arrows). C-D) Axial and coronal CT scan show focal 
consolidation in the left upper lobe (arrow) with adjacent ground glass opacities (arrow heads). E) Coronal CT scan after 3 weeks of antifungal treatment 
shows decreased size of the focal consolidation (arrow) and the presence of air crescent sign (arrowhead) as part of response to treatment. F) Histopatho-
logical microscopy image demonstrating acutely branching, dark, elongated hyphae of Aspergillus
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non-related bone marrow donor, and graft-versus-host 
disease [12,13]. The clinical manifestation of invasive pul-
monary aspergillosis usually occurs 2 weeks after the most 
profound neutropaenia [14]. From a radiologic stance, we 
will focus on IPA, which has 2 main subtypes: angioinvasive 
aspergillosis and airway-invasive aspergillosis [3,6,8]. 
The most common initial manifestations of IPA include 
solid macronodules (≥ 1 cm in diameter, present in 94% of 
patients) with a surrounding halo of ground-glass attenu-
ation classically known as the “halo sign” (present in 61% 
of patients) (Figure 2) [6,15-18]. The halo sign is a non-
sensitive but highly suggestive finding of early IPA in HSCT 
recipients [15,19] and represents a distinct nodule with in-
farction, necrosis, and alveolar haemorrhage [15]. The halo 
sign is also seen in pneumonia-related to Candida, Mu-
cormycosis, herpes simplex virus (HSV), Cytomegalo virus 
(CMV), and other diseases [15,18]. While the halo sign is 
one of the earliest indicators of IPA, it is also short-lived 
[20] and can be easily missed if a CT scan is not conducted 
early during the presentation. Initiation of voriconazole 
therapy based on the presence of halo sign was associated 
with a significantly greater response to treatment and sur-
vival for IPA [15], which provides support for the useful-
ness of early CT imaging in suspected IPA. 
Other commonly seen findings in IPA include con-
solidations, cavitary lesions, and air-crescent sign [14,15]. 
The “hypodense sign” is a highly specific feature of fungal 
infection [14,21] and represents a relative hypodensity/
attenuation within the pulmonary nodule. The hypodense 
sign is a precursor to cavitation and the “air crescent 
sign”, which is a late finding specific for IPA, occurring 
2-3 weeks after resolution of disease [6,14] and indicating 
air occupying the space between retracted necrotic lung 
tissue and the surrounding healthy lung parenchyma. 
The air crescent sign is seen in recovering IPA and should 
not be confused with the similar “monod sign”, which 
describes air surrounding an aspergilloma (mycetoma), 
a focal intracavitary mass in a pre-existing cavity [22].
Less commonly, IPA can affect the airways, referred to 
as airway invasive aspergillosis, and radiological findings in-
clude peribronchial nodular consolidation, branching nod-
ular opacities, centrilobular, and tree-in-bud nodules [23]. 
Surveillance for aspergillus pneumonia can be performed 
by measuring aspergillus galactomannan antigen levels 
(either from bronchoalveolar lavage or serum). However, 
patients may empirically be given antifungal prophylaxis 
(such as voriconazole) [3,9,24].
Mucorales 
The diagnosis “mucormycosis” is an umbrella term mean-
ing any infection related to the fungal order of Mucorales, 
Figure 3. Mucorales pneumonia. A-C) 71-year-old patient with acute myelogenous leukaemia status post haematopoietic stem cell transplantation (HSCT) 
presented with neutropaenic fever diagnosed with Mucorales pneumonia. A) Axial computed tomography (CT) shows focal consolidation of the right 
lower lobe with internal ground-glass opacities and peripheral air crescent. B) Gross pathology images after right lobectomy shows focal haemorrhagic 
infarct in multiple sections (arrows). C) Haematoxylin and eosin histopathology image shows non-septate hyphae with wide angle branching (arrowhead). 
PCR confirmed Rhizopus microsporus. D-E) Separate patient with history of HSCT. D) Initial axial chest CT shows focal right upper lobe opacity with internal 
ground-glass (arrow) surrounded by thick nodular rind of consolidation (arrowhead), commonly termed the “reversed halo sign”. Final diagnosis was Rhi-
zomucor meilhi pneumonia. E) Follow-up CT after 1 week shows evolving cavitation and increased adjacent consolidation
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Figure 4. Candida pneumonia. Patient with history of haematopoietic stem 
cell transplantation. Chest computed tomography demonstrates numerous 
small pulmonary nodules confirmed to be Candida pneumonia (arrows)
which can be lethal and is often seen in patients with im-
munocompromising conditions such as HSCT, neutropae-
nia, diabetic ketoacidosis, or organ transplantation [25]. 
Rhizopus species account for 70% of mucormycosis-related 
fungal pneumonia, with mortality rates > 50% and prefe-
rentially developing in patients with poor phagocytic func-
tion [25].
There are some radiological features on CT that can 
help differentiate mucormycosis from other infections and 
inflammatory aetiologies, including the collective pres-
ence of multiple nodules, pleural effusions, and a “reversed 
halo” sign (central ground-glass attenuation surrounded by 
a rind/zone of consolidation) (Figure 3) [19]. Rarely, a fill-
ing defect due to pulmonary artery invasion can be seen 
[23]. However, from an imaging standpoint, the diagnosis of 
mucormycosis pneumonia may remain indeterminant and 
serial imaging may be necessary to evaluate changes after 
initiation of empiric therapy [26]. Treatments for mucor-
mycosis include oral medications (such as isavuconazole), as 
well as intravenous medications (amphotericin) [24].
Candida
The prophylactic use of “azole” medications (such as flu-
conazole) has significantly decreased the rate of Candida 
species infections (candidiasis) in HSCT patients. The ap-
pearance of candidiasis pneumonia overlaps significantly 
with those discussed previously: nodules, consolidation; 
possible ground-glass halo; and less common patterns in-
clude cavitations and miliary nodules (Figure 4) [6,27]. 
Cryptococcus
Cryptococcosis infections are more often associated with 
conditions related to lymphopaenia and T-cell dysfunc-
tion. Cryptococcosis is caused by Cryptococcus neoformans, 
which can be found in soil throughout the world, more so 
in areas of bird droppings. The infection can involve mul-
tiple organ systems (lungs, skin, central nervous system, 
etc.), and patients may present with a wide range of symp-
toms: fever, mild cough, or acute respiratory failure [28]. 
Radiological features may be best evaluated on CT and 
include pulmonary nodules (solitary or multiple in a mili-
ary pattern; possibly cavitary; possibly interstitial with as-
sociated reticulations), consolidation, pleural effusion, and 
lymphadenopathy (Figure 5) [6,28]. 
Pneumocystis jirovecii
Pneumocystis jirovecii pneumonia (PJP) has declined in 
recent years due to the use of routine post-HSCT trime-
thoprim-sulfamethoxazole (TMP-SMX) prophylaxis [3]. 
The most common radiological appearance of PJP on CT is 
upper lobe predominant (although it may also be diffuse), 
generally peripheral sparing, ground-glass opacities (with 
or without air-filled cysts), which directly reflects the his-
topathology of infectious organism causing intra-alveolar 
accumulation of fibrin and cellular debris [27]. The thin-
walled, air-filled cysts can decrease in size and potentially 
resolve after initiation of treatment, and can also spontane-
Figure 5. Cryptococcal pneumonia. 61-year-old patient with multiple myeloma status post haematopoietic stem cell transplantation (HSCT) presenting with 
neutropaenic fever diagnosed with both cryptococcal fungal infection (right lung) and Pneumocystis jirovecii. A) Axial chest computed tomography shows 
mass-like consolidation in the right upper lobe (arrow), as well as patchy ground-glass opacities. Histopathologic slides: B) Grocott methenamine silver 
(GMS)-stain showing multiple pleomorphic oval shaped budding Cryptococci (arrow heads). C) Mucarmine stain shows the bright red mucinous capsule 
which is characteristic of the multiple pleomorphic oval shaped Cryptococci (short arrows)
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ously rupture, resulting in a pneumothorax [28]. Pleural 
effusion is very uncommon, and the presence of pleural 
effusion should alert the radiologist to the presence of an-
other pathogen or mixed organisms [23].
Endemic fungi
Invasive fungal infections due to endemic fungi are very 
rare and account for 0.6% of cases among HSCT patients 
[11], generally occuring 6 months after HSCT transplan-
tation in endemic areas [28].
Histoplasma capsulatum
In immunocompromised populations, histoplasmosis of-
ten appears as disseminated disease with small pulmonary 
nodules in a military pattern due to hematogenous spread 
of the fungi [6,28]. The presence of pleural effusion and 
mediastinal involvement is uncommon with histoplas-
mosis [23]. During the healing process, the pulmonary 
nodules undergo calcification resulting in a characteristic 
“target lesion” appearance, which is highly suggestive of 
a fungal infection of endemic origin [6,23,28].
Coccidioides immitis
Disseminated coccidioidomycosis radiographically ap-
pears very similar to disseminated histoplasmosis with 
nodules in a military distribution [23,29]. A focus of con-
solidation with hilar and mediastinal adenopathy may 
also be seen [29].
Blastomyces dermatitidis
Blastomycosis infections usually present as central focal 
or patchy consolidation and pulmonary nodules that do 
not tend to calcify [23]. 
Differential diagnosis of fungal pneumonia after 
haematopoietic stem cell transplantation
Other infections can mimic fungal pneumonia in HSCT 
patients including bacterial, viral, or less commonly my-
cobacterial infections. Large nodules and “halo sign” are 
more suggestive of fungal rather than bacterial or viral 
aetiologies [30]. 
Bacterial infections include Gram-negative bacteria, 
such as Pseudomonas and Escherichia coli in the early phase 
after HSCT, and Gram-positive bacteria such as Streptococ-
cus and Staphylococcus species in the late phase after HSCT 
[31]. The most common findings in bacterial infections are 
areas of consolidation, followed by ground-glass opacities, 
reticulations, and centrilobular nodules [30]. Often charac-
terized as “fungal-like bacteria”, Nocardia and Actinomycosis 
infections usually appear as nodules or consolidations that 
cavitate and involve the pleura or chest wall [23]. 
Viral infections often considered in HSCT patients in-
clude CMV pneumonia and RSV pneumonia. The com-
mon radiological findings of viral pneumonia are small 
centrilobular nodules, multifocal consolidations, and 
ground-glass opacities [30]. In immunocompromised 
patients, CMV infection can present with patchy areas of 
consolidations, ground-glass opacities, and small (< 5 mm) 
nodules [32].
Post-transplant intrathoracic lymphoproliferative dis-
order (PTLD) should be considered in the differential pos-
sibilities when there is a lack of response to antifungals. 
PTLD has an overall incidence of 1% in HSCT patients and 
typically occurs within 6 months of transplant [33]. Pulmo-
nary nodules and masses are the most common radiologi-
cal finding followed by lymphadenopathy, which appear hy-
permetabolic on 18F-FDG PET/CT [33,34]. False positives 
due to infectious lesions (such as Aspergillus and Nocardia) 
[34,35] can be avoided by considering the location of the 
lesions, the patient’s clinical symptoms, and laboratory val-
ues such as lactate dehydrogenase levels [35]. PET/CT can 
help identify other sites of extra-thoracic involvement by 
the disease and assess treatment response [36]. Pulmonary 
masses, either solitary or multiple, are the most common 
thoracic manifestations of PTLD, and a pulmonary mass 
is seen in 50% of cases of lung allograft PTLD and nod-
ules in 40-50% of cases. They can have smooth or irregular 
borders and homogeneous soft tissue density on CT. Less 
commonly they can have a hazy halo or central necrosis, 
which mimics pulmonary aspergillosis [34].
Pulmonary oedema, diffuse alveolar haemorrhage 
(DAH), idiopathic pneumonia syndrome (IPS) should be 
considered in patients with diffuse parenchymal opacities 
and rapidly progressive respiratory symptoms without evi-
dence of infection [33].
Organizing pneumonia is an uncommon late complica-
tion of chronic GVHD (2-10% incidence) [33] and should be 
considered in patients with consolidations with reverse halo 
features. Although there is a significant overlap in appear-
ance, organizing pneumonia usually has a smoother rind of 
peripheral consolidation than in reverse halo sign [33].
Diagnostic approach and management
Fungal pneumonia can be diagnosed using non-invasive 
or invasive testing. When fungal pneumonia is suspected, 
a standard clinical workup can include serum galacto-
mannan (GM), respiratory viral panel, other bloodwork, 
and imaging. The diagnostic yield of sputum culture is 
often low [37].
Chest CT and radiography play crucial roles in establish-
ing the likelihood of pneumonia during the infectious work-
up of HSCT patients. Owing to their wide availability, chest 
radiographs are often the first-line imaging obtained during 
an infectious workup in HSCT patients. Radiographs may 
demonstrate readily apparent features of pneumonia, as well 
as provide information about the overall extent of disease/ 
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severity; however, in cases where the radiographs are nor-
mal or when only minimal/subtle features of potential infec-
tion are demonstrated, a chest CT should be obtained, given 
its high negative predictive value in excluding pneumonia 
(Figure 6) [38]. A normal CT study would suggest an extra-
pulmonary source of infection. 
When pulmonary radiological abnormalities are iden-
tified it is important to keep in mind that radiological 
features of infectious pneumonia can overlap with non-
infectious processes, such as pulmonary haemorrhage, 
organizing pneumonia, and diffuse alveolar damage. 
A diffuse pattern of disease is most likely to be sugges-
tive of a viral infection and underscores the importance of 
obtaining a respiratory viral panel in the standard workup. 
The viral panel should include PCR for influenza virus 
A or B, respiratory syncytial virus (RSV), parainfluenza 
viruses, Coronavirus, Rhinovirus, Metapneumovirus, Ade-
novirus, or Bocavirus [37]. If the viral panel is negative for 
infection but suspicion of infection persists, bronchoscopy 
with bronchoalveolar lavage (BAL) is the best next step 
because the BAL fluid is more sensitive for measuring ga-
lactomannan [39] and isolating organisms on Gram stain 
and culture. If bronchoscopy does not yield a diagnosis 
but suspicion of infection remains, image-guided percu-
taneous FNA or biopsy should be considered for definitive 
diagnosis [8]. Imaging is uniquely useful in this setting to 
obtain a targeted transbronchial biopsy that has a high di-
agnostic yield in lesions > 1 cm [8]. Surgical lung biopsy is 
often not possible in HSCT recipients due to neutropaenia 
and thrombocytopaenia [8]. 
The main goal of imaging in fungal pneumonia is to 
identify a source of infection before resorting to an in-
vasive procedure, such as bronchoscopy or percutaneous 
tissue sampling. Additionally, imaging examinations are 
able to evaluate coexisting abnormalities hindering recov-
ery, as well as alternative diagnoses. Imaging should not 
be used to suggest a single/specific organism. Ultimately, 
radiological findings should match the patients’ clinical 
presentation, verified through active communication with 
the clinical team; the patient’s HSCT infectious history 
is imperative. In an asymptomatic immunocompromised 
patient, a radiological examination may be the best test to 
monitor for developing infection, especially because the 
rate of infection is low but is associated with high mortal-
ity [37]. When there is radiological evidence of pneumo-
nia, the role of radiologists is 2-fold: identifying the site 
of greatest disease burden that can be targeted by endos-
copists during BAL, which is becoming standard practice 
for diagnosis pulmonary infection in HSCT patients [40], 
as well as suggesting potential infectious aetiologies that 
could aid in selection of initial medication therapy in cas-
es where endoscopy is not readily available.
Fluconazole is the standard prophylaxis for fungal 
pneumonia. Triazoles, including voriconazole, are usu-
ally used empirically in patients with suspected fungal 
infections with non-Mucorales spp. Amphotericin, which 
is considered a relatively toxic antifungal, is used for the 
treatment of Mucorales spp. Surgical resection is used to 
treat Mucorales spp. 
Radiological follow-up during and after initiation of 
therapy is usually necessary to evaluate treatment response 
[37]. Imaging surveillance for response to treatment of in-
fectious pneumonia in HSCT is generally performed with 
repeat chest radiographs during hospitalization, although 
chest CT may be utilized as well. The goal of imaging is 
to document clearance and/or resolution of the infection. 
When patients are not responding to treatment clinically 
(persistent infectious symptoms) and/or their pneumonia 
is worsening radiologically, this typically triggers clini-
cal re-investigation that may include repeat BAL due to 
possible treatment failure versus development of a new 
infection [41]. If the patient is clinically responding well 
and laboratory findings support a positive response, the 
radiologic features may be merely reflecting a lag time or 
“pseudo-worsening” that requires longer surveillance to 
demonstrate a clearance of infection [20]. There are no 
current guidelines discussing the duration of imaging 
follow-up for the pulmonary findings in patients who are 
Figure 6. Improved radiologic visualization of Mucorales pneumonia between chest radiograph and computed tomography. A 60-year-old woman with 
history of stem cell transplant who presents with fever. A) Frontal chest radiograph demonstrates a subtle opacity (arrow) adjacent to the right heart 
border. B) Sagittal reformat from computed tomography shows central ground-glass opacity (arrowhead) in the right middle lobe surrounded by a rind of 
consolidation (arrow). There is also associated pleural effusion (star)
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responding positively to treatment, but suffice it to say, 
close imaging surveillance is very likely warranted, similar 
to that performed in the general population.
Conclusions
With an ever-growing population of HSCT patients, ra-
diologists should be familiar with imaging features of 
fungal pneumonia to raise the possibility of its presence 
and launch an appropriate clinical investigation, if not 
currently underway. The imaging appearance of a success-
fully treated fungal pneumonia includes cavitation, which 
should not be confused with increased infection. While 
there is overlap and non-specificity in imaging findings of 
fungal pneumonia, the presence of certain findings (halo 
sign or air crescent sign, reverse halo, and target lesion) 
in conjunction with a relevant medical history and geo-
graphical location can help narrow an otherwise broad 
differential. 
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